Twinrix vaccine syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9R17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $157,330
Award facts
- Contract value 100% obligated
- $157,329.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $157,329.97. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor specializing in supplying a broad range of pharmaceutical products and medical supplies to defense and military healthcare systems. The company's contract awards with the Defense Logistics Agency demonstrate extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This specific delivery order for Twinrix vaccine supports the Defense Health Agency and broader military healthcare operations, leveraging AmerisourceBergen's established capacity as a primary pharmaceutical supplier within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9R17?
SPE2DR26F9R17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9R17 worth?
The government has obligated $157,330 on SPE2DR26F9R17.
Is contract SPE2DR26F9R17 an order under another contract?
Yes. SPE2DR26F9R17 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9R17 competed?
The extent of competition for SPE2DR26F9R17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award